<DOC>
	<DOCNO>NCT02558595</DOCNO>
	<brief_summary>The purpose study observe effect niacinamide marker kidney injury , inflammation , kidney cyst growth kidney function .</brief_summary>
	<brief_title>Pilot Study Niacinamide Polycystic Kidney Disease ( NIAC-PKD2 )</brief_title>
	<detailed_description>Polycystic Kidney Disease ( PKD ) genetic disease affect 1 500 people worldwide . It lead kidney failure lead death . PKD cause development kidney cyst ( fluid-filled balloon ) , cause worsen kidney function . It common people PKD also blood urine , kidney pain , high blood pressure , kidney stone , kidney infection , cyst brain part body . There currently treatment know stop cyst growth cure disease . Participants study randomly assign one two group : niacinamide placebo . Participants equal chance assign either group . For people qualify decide participate study , ask make five visit study clinic complete two study relate phone call course 12 month .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Confirmed diagnosis autosomal dominant polycystic kidney disease ( ADPKD ) . Estimated glomerular filtration rate ( eGFR ) &gt; 50 ml/min/1.73m2 determine serum creatinine Chronic Kidney Disease Epidemiology Collaboration ( CKDEPI ) equation Provide Informed consent History liver disease abnormal liver function test Heavy alcohol intake Chronic diarrhea malabsorption syndrome Thrombocytopenia Hypophosphatemia Pregnancy lactation plan become pregnant study Treatment antiepileptic drug Treatment tolvaptan , current within 2 month prior screen Participation another interventional trial currently within 2 month prior screen . Exclusions specific magnetic resonance ( MR ) image acquisition measurement : Partial total nephrectomy renal cyst reduction ( include aspiration ) do &lt; 1 year ago Cardiac pacemaker . Presence MR incompatible metallic clip ( e.g . clipped cerebral aneurysm ) Body weight &gt; 159 kg ( 350 lb ) untreatable claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>PKD</keyword>
	<keyword>Kidney disease</keyword>
	<keyword>Vitamin B3</keyword>
</DOC>